CSDX·June 23, 2026·restatement
CS Diagnostics Says Years of Financials Cannot Be Trusted, Plans Restatement After Removing $499 Million Asset
CS Diagnostics Corp. told investors it can no longer rely on its financial statements from 2022 through 2025 after concluding a $499.4 million intangible asset was improperly recorded.